CONCERT PHARMACEUTICALS, INC. Quarterly Net Cash Provided by (Used in) Financing Activities in USD from Q1 2013 to Q1 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Concert Pharmaceuticals, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q1 2013 to Q1 2022.
  • Concert Pharmaceuticals, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2022 was $0.000, a 100% decline year-over-year.
  • Concert Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $67.1M, a 27.7% decline from 2020.
  • Concert Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2020 was $92.9M, a 6299% increase from 2019.
  • Concert Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2019 was $1.45M.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2022 $0 -$2.66M -100% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-05
Q1 2021 $2.66M -$67.8M -96.2% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q1 2020 $70.5M +$68.7M +3917% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q1 2019 $1.76M +$1.09M +162% Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-30
Q1 2018 $669K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-02
Q1 2014 $83.6M +$83.7M Jan 1, 2014 Mar 31, 2014 10-Q 2014-05-14
Q1 2013 -$83K Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.